Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0000805928-25-000166

Director sold 25,108 shares at $30.98 ($777,771)

  • Director acquired 25,108 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
TYNDALL JOSEPH A. Director 2025-12-09 Option exercise +14,248 $7.04 $100,306 14,248 D: show line 1 in the form
TYNDALL JOSEPH A. Director 2025-12-09 Option exercise +10,860 $10.95 $118,917 25,108 D: show line 2 in the form
TYNDALL JOSEPH A. Director 2025-12-09 Sale −14,248 $30.98 $441,360 10,860 D: show line 3 in the form
TYNDALL JOSEPH A. Director 2025-12-09 Sale −10,860 $30.98 $336,410 0 D: show line 4 in the form
Open-market sales · 25,108 sh · avg $30.98 · $777,771

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
TYNDALL JOSEPH A. Director 2025-12-09 Option exercise · Employee Stock Option (right to purchase) −14,248 0 D: show line 5 in the form
TYNDALL JOSEPH A. Director 2025-12-09 Option exercise · Stock Option (right to purchase) −10,860 32,311 D: show line 6 in the form
Loading xslF345X05/wk-form4_1765405243.xml…